NovaBridge Biosciences (NBP) Total Current Liabilities (2018 - 2026)
NovaBridge Biosciences (NBP) reported Total Current Liabilities of $25.92 million for Q2 2026, up 252.8% from $7.35 million a year earlier.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Total Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, NovaBridge Biosciences posted Total Current Liabilities of $26.89 million, up 218.1% from FY2024.
- Total Current Liabilities has a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
- By year, Total Current Liabilities came in at $8.45 million in FY2024 (-85.5%), $58.14 million in FY2023 (-47.1%), $109.92 million in FY2022 (+12.3%) and $97.92 million in FY2021 (+10.9%).
- Five-year quarterly Total Current Liabilities spans a low of $1.98 million in Q2 2024 and a high of $106.6 million in Q4 2022.
- Year over year, Total Current Liabilities gained in four of the last five quarters, with growth averaging 138.8%.
- The high point for year-over-year Total Current Liabilities in five years was Q2 2025 (growth of 271.8%); the low point was Q2 2024 (a decline of 97.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | NovaBridge Biosciences | 149.78 Mn | 149.78 Mn | - | 25.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.92 Mn |
| Dec 31, 2025 | 26.89 Mn |
| Sep 30, 2025 | 16.09 Mn |
| Jun 30, 2025 | 7.35 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 8.45 Mn |
| Sep 30, 2024 | 11.77 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Dec 31, 2023 | 57.20 Mn |
| Jun 30, 2023 | 91.44 Mn |
| Dec 31, 2022 | 106.60 Mn |
| Jun 30, 2022 | 88.09 Mn |
| Dec 31, 2021 | 97.60 Mn |
| Jun 30, 2021 | 85.28 Mn |
| Dec 31, 2020 | 86.93 Mn |
| Sep 30, 2020 | 51.46 Mn |
| Jun 30, 2020 | 35.57 Mn |
| Dec 31, 2019 | 83.49 Mn |
| Dec 31, 2018 | 50.06 Mn |
API Access
NovaBridge Biosciences Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();